Hemab Therapeutics Holdings, Inc. — Company profile
Healthcare · Biotechnology · United States
Last price 41.29 USD (Oct 30, 2026, 3:42 PM EDT) · Market cap 1.93B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Company profile
Hemab Therapeutics Holdings, Inc. operates as a clinical-stage biotechnology company developing therapies that reimagine the treatment of blood coagulation disorders to sustain life and human resilience in United States of America and Denmark. Its products includes (HMB-001), is a bispecific antibody currently in Phase 1/2 clinical development for the prophylactic treatment of Glanzmann thrombasthenia and Phase 2 clinical development for the prophylactic treatment of Factor VII deficiency; and second clinical-stage asset, HMB-002, is a monovalent antibody in Phase 1/2 clinical development for the subcutaneous prophylactic treatment of Von Willebrand disease. It also advances multiple preclinical and discovery-stage assets. The company was founded in 2020 and is based in Cambridge, Massachusetts.
Details
| Name | Hemab Therapeutics Holdings, Inc. |
| Sector | Healthcare |
| Industry | Biotechnology |
| Founded | 2020 |
| Ipo Date | 2026-05-01 |
| Ceo | Benny Sorensen |
| Country | United States |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| Ipo Price | 18.00 |
| Isin | US4234941031 |
| Cusip | 423494103 |
| Cik | 2114044 |
| Sic | 2836 |
| Stock Type | Common Stock |
Key executives
| Name | Title |
|---|---|
| Dr. Benny Sorensen M.D., Ph.D. | President, Chief Executive Officer and Director |
| Mads Nikolaj Behrndt-Eriksen M.Sc. | Chief Financial Officer and GM |
| Dr. Catherine Eilleen Madigan M.D. | Chief Medical Officer |
| Dr. Ananthram Sreenivasa Murthy M.Sc., Ph.D. | Chief Operating Officer |
| Karen Weisbach | Chief People and Culture Officer |
| Cecile Bonvoisin M.Sc. | Senior Vice President of CMC and Manufacturing |
Contact
| Address | 101 Main Street, Suite 1220, Cambridge, Massachusetts 02142, United States |
| Phone | (617) 553-3952 |
| Website | https://www.hemab.com |